Literature DB >> 18997346

Crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 6.

Qing Xie1, Heather M Ongley, Joan Hare, Michael S Chapman.   

Abstract

Adeno-associated viruses are being developed as vectors for gene therapy and have been used in a number of clinical trials. Vectors to date have been based on the type species AAV-2, the structure of which was published in 2002. There is growing interest in modulating the cellular tropism and immune neutralization of AAV-2 with variants inspired by the properties of other serotypes. Towards the determination of a structure for AAV type 6, this paper reports the high-yield production, purification, crystallization and preliminary diffraction studies of infectious AAV-6 virions. The crystals diffracted to 3.2 A resolution using synchrotron radiation. The most promising crystal form belonged to space group R3 and appeared to be suitable for initial structure determination.

Entities:  

Mesh:

Year:  2008        PMID: 18997346      PMCID: PMC2581704          DOI: 10.1107/S1744309108033290

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  23 in total

1.  Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 1.

Authors:  Edward B Miller; Brittney Gurda-Whitaker; Lakshmanan Govindasamy; Robert McKenna; Sergei Zolotukhin; Nicholas Muzyczka; Mavis Agbandje-McKenna
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-11-30

2.  Structure of adeno-associated virus serotype 8, a gene therapy vector.

Authors:  Hyun-Joo Nam; Michael Douglas Lane; Eric Padron; Brittney Gurda; Robert McKenna; Erik Kohlbrenner; George Aslanidi; Barry Byrne; Nicholas Muzyczka; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

3.  Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.

Authors:  Joseph E Rabinowitz; Fabienne Rolling; Chengwen Li; Hervè Conrath; Weidong Xiao; Xiao Xiao; R Jude Samulski
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Serotype-specific detection of adeno-associated virus during laboratory preparation.

Authors:  Daniel A J Mitchell; Jason O'Donnell; Joan T Hare; Michael S Chapman
Journal:  J Virol Methods       Date:  2006-07-03       Impact factor: 2.014

5.  Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein.

Authors:  Seiichiro Mori; Lina Wang; Takamasa Takeuchi; Tadahito Kanda
Journal:  Virology       Date:  2004-12-20       Impact factor: 3.616

6.  Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

Authors:  E A Rutledge; C L Halbert; D W Russell
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Large-scale production, purification and crystallization of wild-type adeno-associated virus-2.

Authors:  Qing Xie; Joan Hare; Joy Turnigan; Michael S Chapman
Journal:  J Virol Methods       Date:  2004-12-01       Impact factor: 2.014

8.  Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5.

Authors:  Michael DiMattia; Lakshmanan Govindasamy; Hazel C Levy; Brittney Gurda-Whitaker; Amy Kalina; Erik Kohlbrenner; John A Chiorini; Robert McKenna; Nicholas Muzyczka; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-09-30

9.  Seroepidemiological and ecological studies of the adenovirus-associated satellite viruses.

Authors:  W P Parks; D W Boucher; J L Melnick; L H Taber; M D Yow
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

10.  Cloning of infectious adeno-associated virus genomes in bacterial plasmids.

Authors:  C A Laughlin; J D Tratschin; H Coon; B J Carter
Journal:  Gene       Date:  1983-07       Impact factor: 3.688

View more
  13 in total

Review 1.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

2.  Twinned crystals of adeno-associated virus serotype 3b prove suitable for structural studies.

Authors:  Thomas F Lerch; Qing Xie; Heather M Ongley; Joan Hare; Michael S Chapman
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-01-31

3.  Characterization of interactions between heparin/glycosaminoglycan and adeno-associated virus.

Authors:  Fuming Zhang; Javier Aguilera; Julie M Beaudet; Qing Xie; Thomas F Lerch; Omar Davulcu; Wilfredo Colón; Michael S Chapman; Robert J Linhardt
Journal:  Biochemistry       Date:  2013-08-28       Impact factor: 3.162

4.  The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion.

Authors:  Thomas F Lerch; Qing Xie; Michael S Chapman
Journal:  Virology       Date:  2010-05-04       Impact factor: 3.616

5.  Structure-function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6).

Authors:  Qing Xie; Thomas F Lerch; Nancy L Meyer; Michael S Chapman
Journal:  Virology       Date:  2011-09-13       Impact factor: 3.616

Review 6.  Recombinant AAV-directed gene therapy for type I glycogen storage diseases.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Expert Opin Biol Ther       Date:  2011-04-20       Impact factor: 4.388

7.  Reengineered AAV vectors: old dog, new tricks.

Authors:  Aravind Asokan
Journal:  Discov Med       Date:  2010-05       Impact factor: 2.970

8.  AAV's anatomy: roadmap for optimizing vectors for translational success.

Authors:  Angela M Mitchell; Sarah C Nicolson; Jayme K Warischalk; R Jude Samulski
Journal:  Curr Gene Ther       Date:  2010-10       Impact factor: 4.391

9.  Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 9.

Authors:  Matthew Mitchell; Hyun-Joo Nam; Adam Carter; Angela McCall; Chelsea Rence; Antonette Bennett; Brittney Gurda; Robert McKenna; Mark Porter; Yoshihisa Sakai; Barry J Byrne; Nicholas Muzyczka; George Aslanidi; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-06-27

Review 10.  Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy.

Authors:  Michael E Nance; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2015-10-15       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.